全新LC-MS级试剂与软件助力大分子RNA药物分析提速

美通社10-14

(医药健闻2024年10月14日讯)沃特世公司推出一套结合样品前处理酶、试剂与软件的生物分离工具，通过液相色谱质谱联用(LC-MS)分析，简化大分子RNA治疗药物序列和修饰的确认。这套工具有助于加速和改进基于大分子RNA的创新药物开发，如CRISPR sgRNA和mRNA。全新LC-MS级试剂、酶和软件可提高检测灵敏度及准确性，加快mRNA疫苗、个性化癌症疗法和遗传疾病创新药物的开发。 ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2475386190?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-10-14 12:17","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2475386190","market":"sh","top_or_hot":-1,"title":"全新LC-MS级试剂与软件助力大分子RNA药物分析提速","media":"美通社","content":"<div>\n<p>(医药健闻2024年10月14日讯)沃特世公司推出一套结合样品前处理酶、试剂与软件的生物分离工具，通过液相色谱质谱联用(LC-MS)分析，简化大分子RNA治疗药物序列和修饰的确认。这套工具有助于加速和改进基于大分子RNA的创新药物开发，如CRISPR sgRNA和mRNA。全新LC-MS级试剂、酶和软件可提高检测灵敏度及准确性，加快mRNA疫苗、个性化癌症疗法和遗传疾病创新药物的开发。    ...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/usstock/c/2024-10-14/doc-incsnyyz1491509.shtml\">网页链接</a>\n\n</div>\n","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>全新LC-MS级试剂与软件助力大分子RNA药物分析提速</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n全新LC-MS级试剂与软件助力大分子RNA药物分析提速\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-14 12:17 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/usstock/c/2024-10-14/doc-incsnyyz1491509.shtml><strong>美通社</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(医药健闻2024年10月14日讯)沃特世公司推出一套结合样品前处理酶、试剂与软件的生物分离工具，通过液相色谱质谱联用(LC-MS)分析，简化大分子RNA治疗药物序列和修饰的确认。这套工具有助于加速和改进基于大分子RNA的创新药物开发，如CRISPR sgRNA和mRNA。全新LC-MS级试剂、酶和软件可提高检测灵敏度及准确性，加快mRNA疫苗、个性化癌症疗法和遗传疾病创新药物的开发。    ...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/usstock/c/2024-10-14/doc-incsnyyz1491509.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0225283273.USD","symbol_name":"SCHRODER ISF GLOBAL EQUITY ALPHA \"A\" (USD) ACC","start_time":0,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2024-10-14/doc-incsnyyz1491509.shtml","article_id":"2475386190","we_media_id":null,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/usstock/c/2024-10-14/doc-incsnyyz1491509.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2475386190","pubTimestamp":1728879420,"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"沃特世公司推出一套结合样品前处理酶、试剂与软件的生物分离工具，通过液相色谱质谱联用分析，简化大分子RNA治疗药物序列和修饰的确认。全新LC-MS级试剂、酶和软件可提高检测灵敏度及准确性，加快mRNA疫苗、个性化癌症疗法和遗传疾病创新药物的开发。沃特世全新酶类采用两种新型酶的三步简化方法，提供更全面的LC-MS序列覆盖，提高表征可靠性。WatersRapiZymeRNA酶和IonHanceHFIP现已上市，全新MAPSequence应用程序将于2024年10月18日上线。","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0225283273.USD":"SCHRODER ISF GLOBAL EQUITY ALPHA \"A\" (USD) ACC","BK4588":"碎股","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","LU1989772840.SGD":"CPR Invest - Climate Action A2 Acc SGD-H","LU1720051017.SGD":"Allianz Global Artificial Intelligence AT Acc H2-SGD","LC":"LendingClub","LU1720051108.HKD":"ALLIANZ GLOBAL ARTIFICIAL INTELLIGENCE \"AT\" (HKD) ACC","BK4585":"ETF&股票定投概念","LU0320765646.SGD":"FTIF - Franklin Income A MDIS SGD-H1","LU2357305700.SGD":"Allianz Global Artificial Intelligence ET H2-SGD","LU1162221912.USD":"FRANKLIN INCOME \"A\" (USD) ACC","BK4505":"高瓴资本持仓","BK4127":"投资银行业与经纪业","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","LU1548497426.USD":"安联环球人工智能AT Acc","LU1363072403.SGD":"Fidelity Global Financial Services A-ACC-SGD","LU1989772923.USD":"CPR Invest - Climate Action A2 Acc USD-H","BK4166":"消费信贷","LU1668664300.SGD":"Blackrock World Financials A2 SGD-H","LU1074936037.SGD":"JPMorgan Funds - US Value A (acc) SGD","BK4139":"生物科技","RNA":"Avidity Biosciences, Inc.","LU0098860793.USD":"FRANKLIN INCOME \"A\" INC","LU0314104364.USD":"MANULIFE GF AMERICAN GROWTH \"AA\" (USD) INC","LU0106831901.USD":"贝莱德世界金融基金A2","BK4504":"桥水持仓","LU0267386448.USD":"FIDELITY FIRST ALL COUNTRY WORLD \"A\" (USD) INC","LU0971096721.USD":"富达环球金融服务 A","BK4581":"高盛持仓","BK4534":"瑞士信贷持仓"},"translate_title":"New LC-MS-grade reagents and software help speed up the analysis of macromolecular RNA drugs","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RNA":1,"LC":1},"content_text":"(医药健闻2024年10月14日讯)沃特世公司推出一套结合样品前处理酶、试剂与软件的生物分离工具，通过液相色谱质谱联用(LC-MS)分析，简化大分子RNA治疗药物序列和修饰的确认。这套工具有助于加速和改进基于大分子RNA的创新药物开发，如CRISPR sgRNA和mRNA。全新LC-MS级试剂、酶和软件可提高检测灵敏度及准确性，加快mRNA疫苗、个性化癌症疗法和遗传疾病创新药物的开发。    沃特世全新酶类采用两种新型酶（RapiZyme™MC1和RapiZymeCusativin）的三步简化方法，提供更全面的LC-MS序列覆盖，提高表征可靠性。IonHance™HFIP作为LC-MS级联用试剂，提高电离效率及检测灵敏度。waters_connect平台上的MAPSequence应用程序简化了工作流程，加快分析与数据处理过程。这些工具在工作流程中配合使用，可生成指纹图谱，以确认产品特性、纯度及有效性。这些工具改善了序列覆盖率、数据质量及解析能力，并在合规信息学平台支持下，帮助从发现到放行阶段顺利过渡。Waters™RapiZymeRNA酶和IonHanceHFIP现已上市，全新MAPSequence应用程序将于2024年10月18日上线。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2475386190"}